The global cell analysis instruments market is expected to register growth over the forecast period, driven by the rising prevalence of chronic conditions such as cancer coupled with the increasing impact of cell-based diseases, especially on the geriatric population. Furthermore, extending awareness of government bodies towards the global market in the form of grants, investments, and funds for cell-based research activities is the key factor expected to further drive the global market during the forecast period.
The global market is segmented on the basis of application, product, and end-use. On the basis of product, the cell analysis instrument market is segmented into consumables and instruments. The instrument division is further segmented into cell counting instruments, microscope, flow cytometry, high content screening (HCS), spectrophotometer, microfluidics, qRT PCR, cell microarray, consumables market, assay kits, reagents, and microplates. The instrument segment attributes for the largest market share owing to the increasing use of cell analysis instrument for the identification of various cell-based diseases. The market is divided into cell interaction, cell identification, cell viability, cell proliferation, cell structure studies, cell signing pathway, cell counting and quality control, target identification & validation, and single-cell analysis on the basis of application. On the basis of end users, the cell analysis instrument market is categorized into laboratories, contract research organizations (CROs), hospitals, academics, and government institutes and pharmaceutical and biotechnology companies.
North America attributes for the largest share in the market in 2013. The increasing incidences of cancer and increasing corporate & government funding in cell-based research are the major factors fueling the cell analysis instruments market growth in this region. Asia Pacific is expected to witness lucrative growth over the coming six years due to the low cost of cell analysis system and simple regulatory standards for the short approval process in the region.
The Industry witnesses high competition as there are various established and new firms with similar product offerings. These companies adopt various strategies such as collaborations, expansions, and acquisitions to increase their market share and to establish a strong foothold in the global cell analysis instruments market. The key players in the global market include Sigma Aldrich, Dickinson and Company, Becton, Danaher Corporation, and Thermo Fischer Scientific.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.